Telo GenomicsTDSGF -14.56% Operating Margin % is 0.00% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Telo Genomics ranks worse than 490195.59% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Telo Genomics's Operating Income for the
three
months ended in Mar. 2026 was $-0.42 Mil. Telo Genomics's Revenue for the
three
months ended in Mar. 2026 was $0.00 Mil. Therefore, Telo Genomics's Operating Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Telo Genomics's Operating Margin % or its related term are showing as below:
TDSGF's Operating Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -3.195 * Ranked among companies with meaningful Operating Margin % only.
Telo Genomics's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Telo Genomics's Operating Income for the
three
months ended in Mar. 2026 was $-0.42 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.70 Mil.
Telo Genomics (OTCPK:TDSGF) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Telo Genomics Operating Margin % Related Terms
Telo Genomics Operating Margin % Historical Data
* Premium members only.
The historical data trend for Telo Genomics's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TDSGF vs TMO, DHR, IDXX: Operating Margin % Comparison
For the Diagnostics & Research subindustry, Telo Genomics's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telo Genomics Operating Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Telo Genomics's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Telo Genomics's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Telo Genomics's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telo Genomics (TDSGF) has a Operating Margin % of 0.00% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Telo Genomics and its competitors. According to the industry distribution chart, Telo Genomics ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry.
Is Telo Genomics' Operating Margin % too high?
Telo Genomics' current Operating Margin % is 0.00%. Based on the distribution chart, Telo Genomics ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Telo Genomics' Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Telo Genomics ranks #999999 out of 204 companies for Operating Margin %. This places Telo Genomics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Telo Genomics and its competitors. Telo Genomics's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telo Genomics stock overvalued right now?
Telo Genomics (TDSGF) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Telo Genomics (TDSGF), the current Operating Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TDSGF has been successfully added to your 